Shefali Agarwal was named chief medical officer of Epizyme Inc. In this role, Agarwal will oversee all of the company's activities related to the global strategic development of tazemetostat, a potent, selective, orally available EZH2 inhibitor, as well as additional pipeline candidates.
Indiana University Distinguished Professor Hal Broxmeyer received the National Heart, Lung, and Blood Institute Outstanding Investigator Award to continue his 35 years of research into umbilical cord blood transplantation.
Trevor Royce and Sheetal Kircher have been selected for the American Society of Clinical Oncology Health Policy Fellowship Program.
To modernize drug development, FDA plans to add review divisions to its Center for Drug Evaluation and Research and organize those divisions around disease types, FDA Commission Scott Gottlieb said July 25 to members of Congress in a House Energy and Commerce Committee hearing.
Agios Pharmaceuticals Inc., the sponsor of two drugs that may change the outcomes for a subset of acute myelogenous leukemia patients, is focused on more than AML.
As the landscape in acute myelogenous leukemia changes, consultations with top-tier experts have become a necessity, said John Byrd, the principal investigator of Beat AML, Distinguished University Professor, the D. Warren Brown Professor of Leukemia Research at The Ohio State University, a member of the NCI Leukemia Steering Committee, chair of the Leukemia and Correlative Science Committee within the Alliance for Clinical Trials in Oncology.
An actuary might note that if you were in residency at the time when the 7+3 protocol of cytarabine and daunorubicin was first used to treat acute myelogenous leukemia, chances are you are considering retirement just about now.
There are so few individuals who are willing to challenge authority in the world of cancer advocacy. Marlene McCarthy was one of the best at that. Marlene died on July 17; she was 74.
Alan Rabson, one of the premier cancer pathologists of his generation whose most recent title at NCI was scientist emeritus, died on July 4. He was 92.
Murat Tuncer, a pediatric oncologist and former rector of Hacettepe University has spent the past two months in a very uncomfortable place—the Sincan Prison in Ankara.
